Search Results
Inserm U1016, CNRS UMR 8104, Institut Cochin, Université Paris Descartes-Université de Paris, Paris, France
Search for other papers by Chiara Villa in
Google Scholar
PubMed
Department of Neurosurgery, Hôpital Universitaire Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France
Search for other papers by Bertrand Baussart in
Google Scholar
PubMed
Department of Endocrinology, Center for Rare Adrenal Diseases, Hôpital Cochin APHP, Paris, France
Search for other papers by Guillaume Assié in
Google Scholar
PubMed
Lyon 1 University, Villeurbanne, France
Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Lyon, France
Search for other papers by Gerald Raverot in
Google Scholar
PubMed
Search for other papers by Federico Roncaroli in
Google Scholar
PubMed
Staging No staging No staging Dissemination in CSF and MRI/CT/PET No staging: invasion unproven Proliferation markers Ki67: cut off 3% Ki67 (hotspots count): no cut off Ki67 (hotspots count): no cut off Proliferative
Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by C Christofer Juhlin in
Google Scholar
PubMed
Endocrine Oncology Site, Princess Margaret Cancer Centre, Toronto, ON, Canada
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
Search for other papers by Ozgur Mete in
Google Scholar
PubMed
Search for other papers by Zubair W Baloch in
Google Scholar
PubMed
, minimally invasive; EAI, encapsulated angioinvasive; WI, widely invasive. Created using BioRender.com. In this brief review, important changes and updates are highlighted in order to orientate the reader further. Benign follicular cell
Search for other papers by Maria Riedmeier in
Google Scholar
PubMed
Search for other papers by Lester D R Thompson in
Google Scholar
PubMed
Search for other papers by Carlos Augusto Fernandes Molina in
Google Scholar
PubMed
Search for other papers by Boris Decarolis in
Google Scholar
PubMed
Search for other papers by Christoph Härtel in
Google Scholar
PubMed
Comprehensive Cancer Centre Mainfranken, University of Wuerzburg Medical Centre, Wuerzburg, Germany
Search for other papers by Paul-G Schlegel in
Google Scholar
PubMed
Department of Medicine, Division of Endocrinology and Diabetes, University Hospital, University of Wuerzburg, Wuerzburg, Germany
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Comprehensive Cancer Centre Mainfranken, University of Wuerzburg Medical Centre, Wuerzburg, Germany
Search for other papers by Verena Wiegering in
Google Scholar
PubMed
, contains nine criteria: high nuclear grade (Führman G3/G4), >5 mitoses/50 HPF (equivalent to 10 mm 2 ), abnormal rate of mitosis, <25% clear cells, >33% diffuse architecture, tumor necrosis, venous invasion, sinusoid invasion, and capsular invasion
Search for other papers by R Michael Tuttle in
Google Scholar
PubMed
Search for other papers by Duan Li in
Google Scholar
PubMed
Search for other papers by Fourat Ridouani in
Google Scholar
PubMed
appropriate use of hydrodissection, studies are emerging suggesting that nodules that are either abutting without invasion or <2 mm away from an intact thyroid capsule can also be safely and effectively ablated ( Wu et al. 2021 , Zheng et al. 2022